The future of personalized pancreatic cancer treatments across the continuum of multidisciplinary care

This day and a half long, in-person symposium is a combined effort of MSK’s Hepatopancreatobiliary Disease Management Team (HPB DMT) and Center for Pancreatic Cancer Research (CPCR) and will provide a comprehensive review of the epidemiology, genomic, and immunologic features of pancreatic adenocarcinoma and how advances in these areas are impacting current management.   The program will include an emphasis on contemporary management approaches in […]